Amphora Discovery

company

About

Amphora Discovery Corporation operates as a biotechnology company. It provides integrated services to the pharmaceutical industry.

  • 101 - 250

Details

Last Funding Type
Series D
Last Funding Money Raised
$9.55M
Industries
Biotechnology,Data Integration,Pharmaceutical
Founded date
Jan 1, 2001
Number Of Employee
101 - 250
Operating Status
Active

Amphora Discovery Corporation operates as a biotechnology company. It provides integrated services to the pharmaceutical industry. The company's products and services include in vitro assay protocols, in vitro throughput screening and compound profiling services, custom assay development, enzymology services, and lead discovery/lead optimization partnering programs. It offers drug discovery contract research services, HTS, profiling and lead generation, and lead optimization solutions. The company serves pharmaceutical and biopharmaceutical companies, emerging biotechnology companies, and research foundations. Amphora Discovery Corporation was founded in 2001 and is headquartered in Durham, North Carolina. As of July 2008, Amphora Discovery Corporation operates as a subsidiary of Nanosyn Inc.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
6
$94.31M
Amphora Discovery has raised a total of $94.31M in funding over 2 rounds. Their latest funding was raised on Feb 24, 2006 from a Series E round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 24, 2006 Series E $4.37M 3 Detail
Jun 15, 2005 Series D $9.55M 2 Detail
Dec 8, 2004 Series C $20M 2 Detail
Jan 6, 2004 Series B $12.90M 2 Detail
Dec 26, 2002 Series B $12.48M 1 Detail

Investors

Number of Lead Investors
Number of Investors
3
Amphora Discovery is funded by 3 investors. ARCH Venture Partners and Genavent are the most recent investors.
Investor Name Lead Investor Funding Round
ARCH Venture Partners Series E
Genavent Series E
Versant Ventures Series E